Asset Type: Webinars

Can Neuroimaging Save Psychedelic Drug Development?

Can Neuroimaging Save Psychedelic Drug Development?

Presenters:

Matthew Wall, PhD, Associate Director of Translational MRI, Perceptive
Dr. Matthew Wall is a Neuroscientist and Psychologist with expertise in functional MRI and psychopharmacology. He leads translational MRI efforts at Perceptive and holds an honorary academic post at Imperial College London. His research explores how psychedelics like psilocybin and LSD affect brain function, with broader interests in cannabis, sex hormones and fMRI methods. He has held senior imaging roles at Perceptive and Imanova and authored over 90 publications. He is the Editor of the forthcoming book, Pharmacological fMRI: Methods and Applications (2025), which bridges neuroimaging techniques with clinical and drug development applications.